Selective serotonin reuptake inhibitors and Alzheimer’s disease

Given the failure to develop disease-modifying therapies for Alzheimer’s disease (AD), strategies aiming at preventing or delaying the onset of the disease are being prioritized. While the debate regarding whether depression is an etiological risk factor or a prodrome of AD rages on, a key determini...

Descripción completa

Detalles Bibliográficos
Autores principales: Mdawar, Bernadette, Ghossoub, Elias, Khoury, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862425/
https://www.ncbi.nlm.nih.gov/pubmed/31535641
http://dx.doi.org/10.4103/1673-5374.264445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862425/
https://www.ncbi.nlm.nih.gov/pubmed/31535641
http://dx.doi.org/10.4103/1673-5374.264445

Ejemplares similares